Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Aug 1;105(8):e82-e83.
doi: 10.1097/TP.0000000000003850.

Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients

Brian J Boyarsky  1 , Teresa P-Y Chiang  1 , Michael T Ou  1 , William A Werbel  2 , Allan B Massie  1 , Dorry L Segev  1   3 , Jacqueline M Garonzik-Wang  1
Affiliations
Comparative Study

Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients

Brian J Boyarsky et al. Transplantation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

D.L.S. received consulting and speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt, Thermo Fisher Scientific. The remaining authors of this manuscript have no financial disclosures or conflicts of interest to disclose as described by Transplantation.

Figures

Figure 1.
Figure 1.
SARS-CoV-2 Anti-Receptor Binding Domain Antibody Titers Among Recipients of mRNA versus Janssen Vaccine.
See this image and copyright information in PMC

References

    1. Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, et al. Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine. New England Journal of Medicine. 2021. - PMC - PubMed
    1. Custers J, Kim D, Leyssen M, Gurwith M, Tomaka F, Robertson J, et al. Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 2020. - PMC - PubMed
    1. Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C, et al. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021;325(15):1535–44. - PMC - PubMed
    1. Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021. - PMC - PubMed
    1. Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021. - PMC - PubMed

Publication types